Elsevier

Brain Research

Volume 519, Issues 1–2, 11 June 1990, Pages 102-111
Brain Research

Effects of morphine treatment on pro-opiomelanocortin systems in rat brain

https://doi.org/10.1016/0006-8993(90)90066-KGet rights and content

Abstract

In previous studies to determine whether chronic opiate administration might negatively feedback upon endogenous opioid systems in the CNS, investigators found no changes in steady-state concentrations of opioid peptides following morphine pelleting. However, since only steady-state levels were measured, it was still not clear whether morphine treatment altered the release and/or biosynthesis of opioid-containing neurons. The goal of the present study was to assess the effects of chronic morphine pelleting on the dynamics of β-endorphin (βE) biosynthesis in rats. Hence, at several times during a 7-day morphine treatment, concentrations of total βE-immunoreactivity (-ir), as well as chromatographically sieved forms of βE, were determined by RIA, and mRNA levels of pro-opiomelanocortin (POMC) were measured by a solution phase protection assay using a mouse or rat POMC32P-labelled riboprobe. Concentrations of total βE-ir or different forms of βE-ir peptides (i.e. β-lipotropin,βE1–31,orβE1–27/βE1–26) in the hypothalamus or midbrain following either 1 or 7 days of treatment were similar in morphine- and placebo-pelleted animals. However, a significant increase in total hypothalamic βE-ir was observed following 3 days of morphine pelleting; chromatographic analyses indicated that this was primarily due to a selective increase in the opiate inactive forms of βE, i.e.βE1–27/βE1–26. After 7 days of pelleting, morphine-treated animals tended to have lower POMC mRNA levels than those of placebo controls (20 to 50% decrease in different studies). The accumulation of hypothalamic βE-ir at 3 days, and the apparent decline in POMC mRNA levels at 7 days, lend support to the hypothesis that morphine negatively feeds back upon POMC neurons in the brain by inhibiting βE release and biosynthesis.

Reference (37)

  • UhlG.R. et al.

    Morphine alters preproenkephalin gene expression

    Brain Research

    (1988)
  • WatsonS.J. et al.

    Beta-lipotropin: localization in cells and axons in rat brain by immunocytochemistry

  • AkilH. et al.

    Induction of the intermediate pituitary by stress: synthesis and release of a non-opioid form of β-endorphin

    Science

    (1985)
  • AkilH. et al.

    Pro-opiomelanocortin peptide secretion from anterior and intermediate lobe: effect of pre-translational and post-translational events

  • Bals-KubikR. et al.

    β-Endorphin-(1–27) is a naturally occurring antagonist of the reinforcing effects of opioids

    Naunyn-Schmiedeberg's Arch. Pharmacol.

    (1988)
  • BloomF. et al.

    Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies

  • BronsteinD.M. et al.

    Effects of chronic morphine treatment on beta-endorphin immunoreactive forms in rat brain

    Soc. Neurosci. Abstr.

    (1987)
  • DeakinJ.F. et al.

    Influence of N-terminal acetylation and C-terminal proteolysis on the analgesic activity of beta-endorphin

    Biochem. J.

    (1980)
  • Cited by (70)

    • The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data

      2020, Brain Research
      Citation Excerpt :

      Finally, there is also evidence that nicotine administration causes an upregulation of central MC-3R and MC4-R (Tapinc et al., 2017) and that MC4-R blockade blunts stress-induced reinstatement of nicotine-seeking in rats (Qi et al., 2015). Both chronic administration and withdrawal of morphine produces a decrease in the expression of POMC mRNA in the hypothalamus (Bronstein et al., 1990; Le Merrer et al., 2009; Pintér-Kübler et al., 2013) and MC4-R mRNA in the NAc, periaqueductal gray (PAG) and striated nucleus (Alvaro et al., 1996), regions that modulate the reinforcing properties of opioids, opioid tolerance and opioid-induced psychomotor stimulation (Kalivas and Stewart, 1991). On the other hand, acute administration of morphine increases the expression of the mRNA of MC4-R in the amygdala (Starowicz et al., 2003).

    • Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: Vulnerability to relapse to heroin-seeking in rats

      2015, Physiology and Behavior
      Citation Excerpt :

      In support of this concept, correlation analysis between the active lever responding during foot shock-induced reinstatement session and the CPu D2 mRNA levels revealed that the H-RI rats seeking relatively more heroin showed relative lowered CPu D2 mRNA levels. In earlier studies using morphine pellets e.g., [17] or heroin administration by experimenters [18], it was found that POMC mRNA in the hypothalamus was decreased after chronic opiate exposure in rats. In the current study, we examined POMC gene expression in two brain regions (the medial hypothalamus and Me/BLA) after 9 days of abstinence from 7 days of heroin self-administration, and found a significant decrease in the POMC mRNA levels in the medial hypothalamus only.

    • Proopiomelanocortin (POMC) expression and conditioned place aversion during protracted withdrawal from chronic intermittent escalating-dose heroin in POMC-EGFP promoter transgenic mice

      2013, Neuroscience
      Citation Excerpt :

      Hypothalamic POMC neurons have been associated with several physiological functions and behaviors, such as regulation of eating, respiration and limbic excitability, pain perception and analgesia, drug addiction, sexual behavior, locomotion, learning and memory, cardiovascular homeostasis and hypophyseal hormone secretion (Kiefer and Wiedemann, 2004). In early studies using morphine pellets, several research groups have shown that POMC mRNA in the hypothalamus in rats is decreased after chronic morphine pellets (Mocchetti et al., 1989; Bronstein et al., 1990). In the current study, we found POMC expression to be decreased during acute spontaneous withdrawal.

    • Neurobiology of overeating and obesity: The role of melanocortins and beyond

      2011, European Journal of Pharmacology
      Citation Excerpt :

      Thus, infusion of Melatonan II into the ventral tegmental area increases dopamine release in the nucleus accumbens (Lindblom et al., 2001). Other evidence on the influence of melanocortin system on the reward circuitry comes from studies where animals exposed to various addictive drugs show alterations in hypothalamic POMC transcripts (Bronstein et al., 1990; Le Merrer et al., 2009). Also, central administration of Melatonan II facilitates the threshold-lowering effect of amphetamine in a lateral hypothalamic self-stimulation paradigm (Cabeza de Vaca et al., 2002), i.e. melanocortin receptor stimulation increased the rewarding properties of amphetamine.

    View all citing articles on Scopus
    View full text